iGlobe Partners
VC Fund
Singapore, Singapore
iGlobe Partners is a VC fund in Singapore focused on Software and Health Care. iGlobe invests in entrepreneurs and companies poised to become category owners in large addressable markets, either present or created. It adds value to its invested firms by building ecosystems of partners, markets and talents.
- Total investments:
- 72
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries iGlobe Partners invests in
Stages iGlobe Partners invests in
Countries iGlobe Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Seed
- $237k–$7.3M
- Series A
- $1.8M–$64M
- Series B
- $997k–$100M
Investment Focus
Industry
- Software 8 (11%)
- Health Care 6 (8%)
- Medical 5 (7%)
- Biotechnology 5 (7%)
- Manufacturing 5 (7%)
Stage
- Series A 17 (24%)
- Series B 14 (19%)
- Seed 10 (14%)
- Series C 8 (11%)
- Venture - Series Unknown 5 (7%)
Country
- United States 17 (24%)
- Singapore 12 (17%)
- China 2 (3%)
- Japan 2 (3%)
- Indonesia 2 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Arvind Khattar
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Joyce Ng
Partner
|
Partner | Total investments: 11 | Find email | |
Philip Yeo
Chairman
|
Chairman | Total investments: 0 | Find email | |
Robert Chew
Partner
|
Partner | Total investments: 6 | Find email | |
Soo Boon Koh
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 21 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AIsphere focuses on visual multimodal large models and empowering content producers in many sectors and scenarios with AIGC technology. | $139M / Series C / Jul 14, 2026 | ||
| Sound Wave Innovation is a medical device manufacturer and supplier company. They provide ultrasound and shockwave systems. An online inquiry form is available on the company's website. | $16.7M / Series C / May 18, 2026 | ||
| Nura Studios operates as an animation platform built by artists, engineers, and producers. | Seed / Apr 30, 2026 | ||
| AIsphere focuses on visual multimodal large models and empowering content producers in many sectors and scenarios with AIGC technology. | $300M / Series C / Mar 12, 2026 | ||
| Inkbit creats a next-generation additive manufacturing platform that combines 3D printing with machine vision. MIT-trained scientists and engineers combines expertise in industrial systems, design software, and material science to identify and seize opportunities for mass-market additive manufacturing. | $18.8M / Venture - Series Unknown / May 03, 2024 | ||
| Performativ provides a cloud-based wealth management platform that brings portfolio management, investment analytics, trading, reporting, compliance, client communication, and workflow automation into one system. The platform supports wealth managers, asset managers, investment advisors, private banks, financial institutions, and multi-familyoffices, with tools for multi-custodian data aggregation, portfolio rebalancing, order management, digital client portals, integrations, access controls, and audit trails. | $5.9M / Seed / Nov 09, 2023 | ||
| Novelship is a marketplace for buyers and sellers of limited-edition sneakers, apparel, and collectibles from the world's most popular and cutting-edge brands such as Nike, Air Jordan, Yeezy, Supreme, and Kaws. Novelship serves the sneaker and streetwear community with authentic products by carefully curating and professionally authenticatingevery item in its collection. | $10M / Series B / Sep 14, 2023 | ||
| Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, andautomation. | $270M / Series A / Apr 26, 2023 | ||
| Headquartered in Singapore, Accredify is the leading service provider for organisations to create and issue verifiable documents. With a presence in more than nine markets serving 900 clients globally, documents issued by Accredify have been verified close to 7 million times. All digital documents issued by Accredify’s cloud-based system aretamper-proof and traceable back to the source. To verify documents, users simply have to drag and drop the digital document into an online verifier portal; results are instantaneous. In addition to its core value proposition of creating and issuing verifiable documents, Accredify offers a suite of APIs and options for systems-to-systems integration, which means teams can create and prepare verifiable digital credentials at the single click of a button. Accredify’s first vertical was the higher education sector, assisting Asia’s top universities and adult learning institutions in the creation and issuance of digital graduation certificates and transcripts. It was recognised by HolonIQ as one of 2020’s Top 50 Southeast Asia EdTech firms. In July 2020, Accredify ventured into the healthcare sector with the intent of helping the Singapore government manage the COVID-19 pandemic. Accredify assisted in the development of Singapore’s digital verifiable COVID-19 test results known as HealthCerts, an internationally recognized document of an individual’s COVID-19 health status which can be verified with a QR code scan. It was also the first service provider to issue a verifiable COVID-19 swab result in Singapore. Accredify-issued HealthCerts are recognised in more than 32 countries around the world. With a dedicated team that embraces the highest standards of customer service, security, and legal compliance, Accredify’s objective is to be the trusted solution for managing and verifying documents anywhere and anytime. For more information, visit www.accredify.io and follow us on LinkedIn @Accredify | $7M / Series A / Apr 19, 2023 | ||
| Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is locatedin Oxford, Oxfordshire, United Kingdom. | $19.6M / Series A / Nov 21, 2022 | ||
| See all 72 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does iGlobe Partners invest in?
iGlobe Partners invests primarily in Software, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 72 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is iGlobe Partners's check size?
iGlobe Partners typically joins rounds of $237k–$7.3M at Seed, $1.8M–$64M at Series A and $997k–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds iGlobe Partners participates in.
How do I contact iGlobe Partners?
Public channels for iGlobe Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at iGlobe Partners?
The team at iGlobe Partners includes Arvind Khattar (Venture Partner), Joyce Ng (Partner) and Philip Yeo (Chairman), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
